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Division of Chemical Biology, Department of Biology and Biological Engineering, Chalmers University of Technology,
Gothenburg, Sweden
Antimicrobial peptides (AMPs) are a promising alternative to classical antibiotics in
the fight against multi-resistant bacteria. They are produced by organisms from all
domains of life and constitute a nearly universal defense mechanism against infectious
agents. No drug can be approved without information about its mechanism of action.
In order to use them in a clinical setting, it is pivotal to understand how AMPs work.
While many pore-forming AMPs are well-characterized in model membrane systems,
non-pore-forming peptides are often poorly understood. Moreover, there is evidence that
pore formation may not happen or not play a role in vivo. It is therefore imperative to
study how AMPs interact with their targets in vivo and consequently kill microorganisms.
This has been difficult in the past, since established methods did not provide much
mechanistic detail. Especially, methods to study membrane-active compounds have
been scarce. Recent advances, in particular in microscopy technology and cell biological
labeling techniques, now allow studying mechanisms of AMPs in unprecedented detail.
This review gives an overview of available in vivo methods to investigate the antibacterial
mechanisms of AMPs. In addition to classical mode of action classification assays,
we discuss global profiling techniques, such as genomic and proteomic approaches,
as well as bacterial cytological profiling and other cell biological assays. We cover
approaches to determine the effects of AMPs on cell morphology, outer membrane,
cell wall, and inner membrane properties, cellular macromolecules, and protein targets.
We particularly expand on methods to examine cytoplasmic membrane parameters,
such as composition, thickness, organization, fluidity, potential, and the functionality of
membrane-associated processes. This review aims to provide a guide for researchers,
who seek a broad overview of the available methodology to study the mechanisms of
AMPs in living bacteria.
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INTRODUCTION
The discovery of antibiotics has been a major historical milestone. With formerly deadly diseases
now being curable with a simple pill, life expectancy, and quality of life increased significantly.
The golden age of antibiotics, characterized by the frequent discovery of new lead structures, lasted
until the late 1980’s. Unfortunately, since the 1990’s antibiotic discovery has stagnated while the
emergence of multi-resistant bacteria has resulted in untreatable superbugs (Goic-Barisic et al.,
2016; Mobarki et al., 2019). The urgent need for new antibiotics prompted a range of interesting
alternative strategies and molecules (Spellberg et al., 2015; Silva et al., 2016; Singer et al., 2019).
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In order to tackle the antibiotic resistance crisis, novel
compounds and novel mechanisms are essential. Bacteria possess
a plethora of possible drug targets, yet only few are currently
clinically exploited. One promising class of new antibiotic
molecules are antimicrobial peptides (AMPs) (Silva et al., 2016;
Wang et al., 2016). These omnipresent compounds occur in all
domains of life and constitute an effective host defense strategy
(Baltzer and Brown, 2011). AMPs are usually defined as up
to 100 amino acids long, possess cationic, hydrophobic, and
amphipathic properties, and typically target the bacterial cell
membrane. Despite these relatively common features, they are a
highly diverse class of molecules, both regarding their structures
and mechanisms of action (Table 1). The best characterized
AMPs are classical pore formers. Different models exist for
this mode of action, including the classical barrel stave, the
toroidal pore and carpet mechanisms as well as the newer
molecular electroporation, sinking raft, and interfacial activity
models (Miteva et al., 1999; Pokorny and Almeida, 2004; Chan
et al., 2006; Wimley, 2010; Teixeira et al., 2012). Accordingly,
mechanisms of AMPs were predominantly investigated using
model lipid systems (in vitro). However, more and more AMPs
are being discovered that have more complex or more subtle
interactions with bacterial membranes and do not form pores
[e.g., MP196, cWFW, and daptomycin (Wenzel et al., 2014;
Scheinpflug et al., 2017; Gray and Wenzel, 2020a)], or do not
target membranes at all (Brötz et al., 1998a; Graf et al., 2017;
Mishra et al., 2018).
The road to clinical approval can be long and rocky and
elucidating the mechanism of action of a new antibiotic can be
challenging. Over the last years, a number of methods have been
developed, adapted, and refined to investigate the mechanisms of
antibiotics in living bacterial cells. This is essential, since the in
vivo mechanism of a compound can be fundamentally different
from its action in artificial models or themolecule may havemore
than one target, a relatively common feature for AMPs (Sass et al.,
2010; Müller et al., 2016b; Wenzel et al., 2019).
In this review, we want to give an overview of the
tools available to investigate the in vivo mechanisms of both
membrane-active AMPs and AMPs with other targets. Thereby,
we do not aim to provide an exhaustive list of techniques
or detailed summary of all recent technical developments. We
rather want to provide a broad handbook for researchers, who
are more or less acquainted with mode of action studies, to
guide them through a range of possibilities for analyzing the
mechanisms of their compounds. While this article is focused on
techniques available for studying AMPs, most assays are perfectly
suitable to analyze other antibiotic molecules as well. We put
special emphasis on analyzing the bacterial cell envelope, but
also address other possible targets. Where possible, we selected
techniques that can be relatively easily adapted and tried to avoid
very specialized niche techniques.
COMPOUND LOCALIZATION
Knowing where an antimicrobial compound accumulates in
the bacterial cell can give a first hint toward the localization
of its target structure. Different labeling approaches have been
developed that allow either the detection of compounds in
subcellular fractions (e.g., cytosolic, membrane, and cell wall
fractions), or the microscopic visualization of antimicrobial
molecules. Although being very useful, the chemical labeling of
a molecule is bound to change its properties and can change
its antimicrobial activity or mechanism of action (Phetsang
et al., 2014, 2016; Omardien et al., 2018b; Stone et al.,
2018, 2019). Mass spectrometry-based label-free technologies
constitute an alternative, yet do not allow visualization
of compound localization. The individual advantages and
disadvantages of common localization techniques are discussed
in the following chapter.
Radioactive Labeling
Radioactive labeling is the oldest approach to labeling a molecule
for following its subcellular distribution and at the same
time only minimally invasive to the compound’s structure:
Radioactive isotopes are generally thought not to affect the
chemical properties of a given compound. However, even the
mass of an atom can affect its chemical bonds. Thus, mass
isotopes can still change the behavior of a labeled molecule
(Filiou et al., 2012; Fleming et al., 2014). Radioactive labeling
is normally only suitable for antibiotics that can be produced
at least semi-synthetically, but it is also possible to obtain
radioactively labeledmicrobially produced antibiotics by growing
the producer strain on a radioactive precursor (Atzrodt and
Allen, 2011). Radioactive labeling allows very sensitive detection
of compounds in subcellular fractions (Perkins and Nieto, 1970;
Ishiguro et al., 1981), but it does not allow the visualization of
antibiotic localization. Due to these drawbacks and the overall
trend to reduce the amount of radioactive material used in
research, radioactive labels are typically no longer the method
of choice for localizing antimicrobial molecules. However, it may
still have its uses in some cases (e.g., for very small molecules that
are dwarfed by large fluorescence tags).
Metal Labeling
A newer approach is metal labeling of antimicrobial compounds.
This technique was largely inspired by a ferrocene-containing
derivative of the antimalarial drug chloroquine (Biot et al.,
2011). Since iron is an electron-dense metal, it should be
possible to detect it by electron microscopy. However, iron
occurs in bacterial cells in relatively high concentrations,
which could lead to a high background signal. This led to
the development of a ruthenocene-containing derivative,
which was successfully employed to detect the compound
in ultrathin sections of malaria parasites (Biot et al.,
2012). A similar approach was then employed for a small
hexapeptide antibiotic by exchanging the N-terminal amino
acid for ruthenocene. This allowed both the visualization
of the peptide by electron microscopy and quantification
in subcellular fractions by element analysis (Wenzel et al.,
2014).
While in this case the activity and mechanism of action
of the labeled compound were not notably compromised
(Wenzel et al., 2014), it is well-possible that the addition
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TABLE 1 | Overview of different AMPs and antimicrobial proteins and their modes of action.
Peptide Peptide class Mode of action References
Daptomycin Cyclic lipopeptide Inserts into fluid membrane microdomains that harbor cell envelope synthesis
complexes; inhibits cell wall and membrane synthesis by displacing the MurG and
PlsX proteins; binds phosphatidylglycerol and undecaprenyl-bound cell wall
intermediates
Müller et al., 2016b;
Grein et al., 2020
Polymyxin B Cyclic lipopeptide Binds to lipopolysaccharides and permeabilizes the outer membrane; integrates into
and permeabilizes the cytoplasmic membrane; inhibits respiration
Vaara, 1992; Fu et al.,
2019
Surfactin Cyclic lipopeptide Membrane permeabilization; local destabilization of membrane packing at low
concentrations, detergent-like membrane solubilization at high concentrations
Carrillo et al., 2003;
Henry et al., 2011
Bacitracin Cyclic peptide Binds to undecaprenylphosphate and leads to inhibition of wall teichoic acid and lipid
II synthesis
Ruhr et al., 1971
Gramicidin S Cyclic beta-sheet peptide Induces large-scale membrane phase separation and delocalizes peripheral
membrane proteins involved in cell division and cell envelope synthesis
Wenzel et al., 2018a
Tyrocidine A Cyclic beta-sheet peptide Induces membrane phase separation and forms large transmembrane pores;
interferes with DNA-binding proteins and probably induces DNA damage
Ristow et al., 1975;
Wenzel et al., 2018a
Theta-defensin Cyclic beta-sheet peptide Membrane interaction of theta defensin leads to deregulation of autolytic enzymes
and indices autolysis




Disturbs membrane organization and delocalizes cytochrome c, MurG, and MinD,
resulting in inhibition of respiration, cell wall synthesis, and cell division
Wenzel et al., 2014
cWFW RW-rich, cyclic CAMP Separates membrane lipids into fluid and rigid domains, resulting in separation of
integral and peripheral membrane proteins in the respective domains, in turn leading
to separation of multiprotein complexes
Scheinpflug et al., 2017
LL-37 Alpha-helical CAMP Membrane disruption by carpet mechanism Kościuczuk et al., 2012
Aurein 2.1 Alpha-helical CAMP Forms cation-selective transmembrane pores Cheng et al., 2009;
Wenzel et al., 2015b
Gramicidin A Alpha-helical peptide Na+/K+ channel ionophore Duax et al., 1996
Magainin Alpha-helical peptide Forms a toroidal membrane pore Ludtke et al., 1996
Alamethicin Alpha-helical peptaibol Forms voltage-dependent ion channels Leitgeb et al., 2007
Vancomycin Glycopeptide Inhibits cell wall synthesis by binding to the D-Ala-D-Ala motif of lipid II Schneider and Sahl,
2010
Nisin Type A lantibiotic Binds to lipid II and uses it as a docking molecule to form a transmembrane pore Breukink et al., 1999
Mersacidin Type B lantibiotic Inhibits cell wall synthesis by binding lipid II Brötz et al., 1998b
hBD3 Beta defensin Interacts with membranes and displays low affinity for lipid II; probably localizes to
sites of active cell wall synthesis and sterically hinders the interaction of protein
complexes
Sass et al., 2010
Plectasin Fungal defensin Inhibits cell wall synthesis by binding to lipid II Schneider et al., 2010
Microcin Lasso peptide Depolarizes bacterial membranes, stabilizes gel phase in bacterial membrane mimics,
RNA polymerase may be an additional target
Delgado et al., 2001;
Rintoul et al., 2001,
2015
Valinomycin Depsipeptide Potassium carrier ionophore Duax et al., 1996
Teixobactin Macrocyclic depsipeptide Inhibits cell wall synthesis by binding bactoprenol-coupled cell wall precursors Ling et al., 2015
ADEP Acyldepsipeptide Deregulates the ClpP protease, leading to uncontrolled proteolysis of substrates like
FtsZ, inhibiting cell division
Brötz-Oesterhelt et al.,
2005; Sass et al., 2011
Lysozyme Antibacterial protein Lyses the peptidoglycan cell wall by hydrolyzing glycosidic bonds Aminlari et al., 2014
Actinonin Peptidomimetic Inhibits peptide deformylase leading to accumulation of formyl-methionine-capped
proteins
Chen et al., 2000
of a metallocene tag will influence the behavior of the
compound in one way or another. However, metallocenes are
still considerably smaller than common fluorescence labels and
thus less likely to severely change the antibiotic properties of
a molecule.
Compounds that already contain a residue that can be
visualized by electron microscopy (electron-dense metals) or
detected by atomic spectroscopy (most elements that do not
occur in bacterial cells in high concentrations) can easily be
localized without additional labeling (Wenzel et al., 2013).
Similarly, AMPs may be visualized with electron microscopy
without the need to chemically label them through specific
detection with gold-labeled antibodies (Azad et al., 2011).
However, this approach requires that the peptide is immunogenic
enough to obtain specific antibodies, a property that is normally
not desired for antibiotic candidates.
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Fluorescence Labeling
While metal labels only allow the visualization of antimicrobial
compounds in fixed cells, fluorescence labels allow live cell
imaging of antibiotic attacks on bacterial cells and even co-
localization of the antimicrobial molecule with its target. It is
a relatively common approach and has aided several mode of
action studies so far (Tiyanont et al., 2006; Pogliano et al., 2012;
Scheinpflug et al., 2013; Chileveru et al., 2015; Müller et al.,
2016b; Omardien et al., 2018b). Most fluorophores have much
higher molecular weights than the average antibiotic. Direct
labeling with such large moieties may critically influence activity,
uptake, and mechanism of action (Katritzky and Narindoshvili,
2009; Müller et al., 2016b; Stone et al., 2019). Even very
small fluorescence labels might already compromise antibacterial
activity (Scheinpflug et al., 2013). Direct fluorescence labeling
approaches can therefore be restricted to larger molecules, which
are not severely affected by the addition of a fluorophore
(Tiyanont et al., 2006; Chileveru et al., 2015). This generally
makes this approach better suited for AMPs than for small
molecule antibiotics.
In any case, possible effects of the label on the compound’s
behavior need to be carefully assessed. This should not be
limited to assaying antimicrobial activity alone but also extend
to phenotypical characterization to ensure that the compound’s
mechanism of action has not notably changed. However, the
use of fluorescent labels always remains a trade-off between
their versatility in live cell microscopy and the possibility that
observations made with the labeled compound may not fully
translate to its unlabelled original.
An alternative to direct the labeling of AMPs is
immunolabelling with fluorescently labeled antibodies. While
this approach does not affect the behavior of the compound and
still allows microscopic localization studies, it is not suitable for
live cell imaging, since it requires permeabilization and chemical
fixation of the cells (Choi et al., 2016).
Label-Free Detection
Label-free detection of antimicrobial compounds by mass
spectrometry is an alternative approach that does not have the
drawback of compromised activity of labeled compounds. As
long as the mass of the molecule of interest is known, it is
possible to detect the unlabeled compound in a complex mixture
such as cell lysate (Ackermann et al., 1996; Deltombe et al.,
2019). This can be used to directly detect and quantify antibiotic
concentrations in subcellular fractions. Interestingly, a new
approach called 3D imaging cluster Time-of-Flight secondary ion
mass spectrometry allowed the label-free detection and mapping
of antibiotics in single cells of Escherichia coli (Tian et al.,
2017). The relatively low spatial resolution of this technique
does not allow the visualization of antibiotics to specific cell
structures and is therefore not well-suited for mode of action
studies yet. However, it gives hope that label-free tracking of
antibiotics within bacterial cells might indeed become possible
at some point.
However, one limitation that will always remain is that mass
spectrometry-based techniques do not allow visualization of
antibiotics in living cells. This is an important limitation since
more and more evidence is emerging that membrane-targeting
AMPs do not uniformly attack the lipid bilayer but instead target
specific foci and that their interaction with bacterial membranes
can be highly dynamic (Kandaswamy et al., 2013; Rangarajan
et al., 2013; Müller et al., 2016b; Rashid et al., 2016). To date,
fluorescence labeling remains the only technique that is suitable
for capturing these dynamic interactions.
FINDING THE PATHWAY
While the localization of an antimicrobial compound within its
target cell helps narrowing down its potential molecular target,
it does not give insight into the process or pathway that is
actually inhibited and basing hypotheses on localization alone
can be misleading. Thus, finding the primarily inhibited pathway
is of crucial importance to proceed with detailed mode of action
analysis and identifying the molecular target. Classically, this has
been done by radioactive precursor incorporation studies, but
more recent alternatives include fluorescently labeled precursors
and reporter gene fusion.
Incorporation of Radioactive Precursors
Incorporation experiments with radioactively labeled precursors
for the main cellular macromolecules (DNA, RNA, proteins,
lipids, peptidoglycan) are very sensitive. While radioactive
labeling is commonly sought to be avoided for safety and
environmental concerns, it is the only method that allows the
detection of macromolecules without altering their chemical
structure and thus has the lowest risk of labeling-imposed
artifacts. Custom synthesis of radioactively labeled molecules
is possible, but commonly used isotopic precursors include
[14C] glucosamine for peptidoglycan, [14C]-thymidine for DNA,
[3H]-uridine for RNA, L-[14C]-isoleucine and [3H] glycine
for proteins, and [14C]-acetate for lipids (Hofmann and
Eichenberger, 1998; Ling et al., 2015; Müller et al., 2016b).
Some of these labels can be combined in the same sample [e.g.,
[14C] glucosamine and [3H] glycine (Molenkamp and Veerkamp,
1976)], yet individual samples are more commonly used). It
has to be noted that in order to assess incorporation into
macromolecules and not just uptake into cells, samples must be
precipitated [e.g., using trichloroacetic acid, prior to measuring
radioactivity (Wenzel et al., 2014)]. However, measuring whole
cells in parallel is a useful control for cellular uptake, since AMPs
often depolarize the cell membrane, which may affect the activity
of nutrient uptake systems.
Fluorescent Labeling of Cellular
Macromolecules
An alternative to radioactive labeling of metabolites is constituted
by fluorescent labeling. A range of fluorescent molecules have
been developed that can be used to cover some of the major
metabolic pathways of bacterial cells. The simplest example for
this is probably the expression of a fluorescent protein, such
as green-fluorescent protein (GFP), from a housekeeping or
inducible promoter, which allows monitoring of active protein
synthesis in living bacterial cells (Gray et al., 2019). A more direct
approach is metabolic labeling of nascent peptide chains with the
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amino acid analog L-homopropargylglycine (L-HPG), followed
by fluorescent labeling of this molecule with Alexa-594 by click
chemistry (Stempler et al., 2017; Gray et al., 2019). Several similar
probes have been described and specific reporters for certain
posttranslational modifications are available as well (Grammel
and Hang, 2013).
Incorporation of cell wall material can be monitored by
fluorescent D-amino acids or sortase-mediated incorporation
of fluorescently labeled lipid II (Nelson et al., 2010; Kuru
et al., 2012, 2015; Hsu et al., 2017). Similarly, fluorescently
labeled glycans can be incorporated into the Gram-negative
or mycobacterial outer membrane (Siegrist et al., 2015). These
techniques are described in detail under 6.2 Cell wall and 6.1
Outer membrane, respectively.
Fluorescent nucleotide analogs that can be incorporated into
DNA or RNA have been developed for eukaryotic cells, but their
suitability for bacterial cells has not yet been explored (Grammel
and Hang, 2013).
Fluorescent labeling of metabolic precursors is superior to
radioactive labeling in terms of safety and official regulations, can
be visualized in living bacterial cells, and in some cases allows
further analysis of the labeled macromolecules, for example by
affinity purification of the tag followed by mass spectrometry
(Grammel and Hang, 2013). However, it is an inherent limitation
of chemically modified precursors that they may not behave
exactly as the unlabeled molecule. This can be due to the size
of the fluorescent tags, which are often larger than the precursor
itself, or simply to changing the physicochemical properties of the
target molecule (Siegrist et al., 2015).
Reporter Gene Fusions
A simple alternative to precursor incorporation studies are
reporter gene fusions. Bacteria react to stress in a highly specific
manner. So much so that the stress response can be used as a
diagnostic tool to identify antibiotic mechanisms of action (see
also four Profiling approaches) (Bandow et al., 2003). Based on
this, specific reporters can be selected for mapping the inhibited
pathway, analogous to precursor incorporation experiments
(Urban et al., 2007). To this end, either the gene of interest or
only its promoter, is fused to a gene encoding a reporter protein,
whose expression can be visualized by calorimetric, fluorescent,
or luminescent measurements. Themost common reporter genes
encode firefly luciferase or beta-galactosidase, but fluorescent
proteins like GFP are also possible.
The main advantage of this method is that it does not need
radioactive labeling, does not produce artifacts by chemical
modification of precursors, and does not require any major or
unusual equipment. However, the choice of reporter genes or
promoters requires solid knowledge of bacterial stress responses
and a new set of strains has to be constructed for each organism of
interest. This also limits it to model organisms that are genetically
accessible. Thus, reporter gene approaches for antibiotic mode of
action analysis are most common in the standard Gram-positive
and Gram-negative model organisms Bacillus subtilis and E. coli
(Table 2) (Bianchi, 1999; Hutter et al., 2004a; Urban et al., 2007;
Wenzel et al., 2014). However, reporter gene studies in general
are common tools in many organisms, including pathogens like
S. aureus, and also strains that were not developed as antibiotic
mode of action analysis tool can prove useful as such (Mesak
et al., 2008; Chanda et al., 2009; Mondal et al., 2010; Dengler and
McCallum, 2016; Bojer et al., 2017).
New reporter gene tools are constantly developed and refined.
For example, a modified luciferase reporter assay reporting
on cell wall synthesis and DNA integrity enables antibiotic
mode of action analyses and screening of new drugs against
Mycobacterium tuberculosis (Naran et al., 2016). Efforts to enable
cost-efficient high through put screenings with reporter gene
fusions have recently resulted in the development of a phenomics
screening platform containing an E. coli reporter gene library
enabling large-scale gene expression studies in a cost- and time-
efficient manner (French et al., 2018).
PROFILING APPROACHES
While precursor incorporation and reporter gene experiments
offer a great way to quickly identify the affected pathway, they
only scratch the surface. A much deeper understanding is made
possible by -omics approaches that allow global profiling on
genomic, transcriptomic, proteomic, and metabolomic level.
These techniques are very useful for generating hypotheses about
antibiotic mechanisms but can rarely stand all alone. While
they offer a large amount of information, complex datasets also
require a significant amount of time for analysis and may be
difficult to interpret for antimicrobial compounds with multiple
or pleiotropic effects, which is often the case for AMPs.
-omics approaches are certainly not a must in mode of action
analysis of “typical” AMPs that impair membrane integrity,
but they allow an unmatched combination of breadth and
depth of physiological insight and can be extremely valuable for
compounds with unknown/unusual mechanisms. The amount
of technical variations, especially in mass spectrometry-based
proteomics, is immense and we do not remotely attempt to
cover them all. In the next chapter we want to present selected
techniques that have a well-established standing in antibiotic
mode of action studies.
Genomic Profiling
Genomic-driven approaches have gained much attention in
antibiotic drug discovery, mainly as sources for new antibiotic
targets (Miesel et al., 2003; Freiberg et al., 2005). However,
genomic approaches can also aid in identifying antibiotic targets.
They can be roughly divided into two groups, screening existing
libraries and generating new mutant libraries.
For both E. coli (Baba et al., 2006) and B. subtilis (Koo
et al., 2017), commercially available mutant collections exist
that comprise deletion strains of each non-essential gene.
These collections can be screened against hypersensitivity to or
resistance against an antibiotic of interest to discover potential
resistance factors or target candidates, respectively. This has
been systematically approached by Tamae et al. and Liu et al.,
resulting in sensitivity patterns for close to 30 different antibiotic
compounds (Tamae et al., 2008; Liu et al., 2010), which can be
used as a reference for studying novel drug candidates (Tran
et al., 2011; Kang et al., 2012). One obvious limitation of this
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TABLE 2 | Examples of reporter gene fusions commonly used to identify antibiotic mechanisms.
Promoter Fusion Species Reporter for References
bmrC Luciferase B. subtilis Inhibition of translation Wenzel et al., 2014
fabHB Luciferase B. subtilis Inhibition of fatty acid synthesis Hutter et al., 2004a
glpD Luciferase B. subtilis Inhibition of fatty acid synthesis Hutter et al., 2004a
Held Luciferase B. subtilis Inhibition of transcription Wenzel et al., 2014
liaI Luciferase B. subtilis Inhibition of cell wall synthesis Wenzel et al., 2014
yheI Luciferase B. subtilis Inhibition of protein synthesis Urban et al., 2007
yorB Luciferase B. subtilis DNA damage Wenzel et al., 2014
ypbG Luciferase B. subtilis Inhibition of cell wall synthesis Hutter et al., 2004a
ypuA Luciferase B. subtilis Cell wall stress Hutter et al., 2004a
yrzI Luciferase B. subtilis Inhibition of protein synthesis Hutter et al., 2004a
yvgS Luciferase B. subtilis Inhibition of RNA synthesis Urban et al., 2007
drp35 β-galactosidase S. aureus Inhibition of cell wall synthesis Mondal et al., 2010
dnaK β-galactosidase E. coli Protein misfolding Bianchi, 1999
Ibp β-galactosidase E. coli Protein misfolding Bianchi, 1999
P3rpoH β-galactosidase E. coli Extracytoplasmic stress Bianchi, 1999
degP) β-alactosidase E. coli Extracytoplasmic stress Bianchi, 1999
approach is that it does not include essential genes, which are
commonly thought to be the most suitable antibiotic targets.
Recently, CRISPR knock-down libraries covering essential genes
have been established for both B. subtilis and E. coli (Peters et al.,
2016; Guo et al., 2018; Wang et al., 2018). Both libraries have
been made commercially available. While they have not yet been
used in antibiotic mode of action studies, they complement the
genomic toolbox available for such approaches. However, when
working with such mutant libraries, care has to be taken that
relevant strains are independently confirmed and that updated
annotations of the mutated open reading frames are taken into
account (Baba et al., 2006; Yamamoto et al., 2009; Aedo et al.,
2019).
The second approach aims at generating resistant mutants
that may reveal the molecular target of an antimicrobial
compound. This can for example be done by characterizing
spontaneous resistant mutants generated under lower antibiotic
pressure or repeated passaging of incrementally resistant
colonies on rising antibiotic concentrations (Leejae et al., 2013;
Puertolas-Balint et al., 2020). The latter is prone to result in
accumulation of different mutations, complicating analysis and
interpretation, and is likely to result in unstable mutants due
to the combined fitness costs of multiple mutations (Leejae
et al., 2013). An alternative approach is the generation of
mutants by chemical or transposon mutagenesis followed
by selecting for antibiotic-resistant colonies. Thereby,
transposon mutagenesis is the easier option, since it allows
rapid identification of the insertion locus by sequencing from
the transposon sequence (Santiago et al., 2018). In contrast,
spontaneous mutants and chemical mutagenesis require
whole genome sequencing to map individual mutations.
However, transposon mutagenesis precludes analyzing
targets encoded by essential genes, while spontaneous and
chemically induced mutations do not necessarily result in loss
of function.
Transcriptomic Profiling
While genomic approaches map the level of antibiotic sensitivity,
transcriptomic and proteomic approaches map the stress
response profiles of bacteria to antibiotic stress, which are
diagnostic for the individual compound’s mechanism of action
and can aid target identification (Bandow et al., 2003;
Bandow and Hecker, 2007; Wenzel and Bandow, 2011).
While microarrays have been the predominant technique for
transcriptomic profiling for a long time, RNA sequencing is now
the method of choice in most cases, since it is more sensitive,
does not rely on hybridization probes, and is becoming more and
more affordable (Hutter et al., 2004b; Gilad et al., 2009; O’Rourke
et al., 2020). Many studies have successfully used transcriptomic
profiling to aid mode of action analysis (Briffotaux et al., 2019;
O’Rourke et al., 2020) and its uses have been extensively reviewed
elsewhere (Freiberg et al., 2004; Wecke and Mascher, 2011).
However, it should be noted that parameters for stress response
profiling, be it transcriptomic or proteomic experiments, must
be chosen with care. Thus, sublethal antibiotic concentrations
and short treatment times should be used in order to achieve the
best possible acute stress response (Wenzel and Bandow, 2011;
Raatschen and Bandow, 2012).
Proteomic Profiling
While transcriptomic profiling is well-suited to monitor
antibiotic stress responses, proteomic profiling can provide
additional information on posttranslational modifications and
regulation mechanisms, such as proteolysis. Metabolic labeling,
either radioactively for gel-based proteomics or with stable
isotopes for mass spectrometry, allows highly sensitive pulse and
pulse-chase experiments for monitoring acute stress responses at
a given time point.
Gel-based proteomics by two-dimensional polyacrylamide
gel electrophoresis (2D-PAGE) is a proteomic approach that
has been extensively employed in stress response profiling and
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antibiotic mode of action research (Bandow et al., 2003; Mostertz
et al., 2004; Wecke et al., 2009). To this end, newly synthesized
proteins are radioactively pulse labeled with L-[35S] methionine
and, after a crude protein extraction, separated according to
their isoelectric point and molecular weight. Protein expression
is then densitrometrically quantified from autoradiographs of
dried gels and compared to an untreated control to acquire
regulation factors. Upregulated proteins, referred to as marker
proteins, are identified by mass spectrometry. These proteins
reflect the acute stress response of the bacterial cells to the given
stress condition and are indicative of the antibiotic mechanism of
action. A reference compendium with protein expression profiles
of over 100 antimicrobial compounds has been established to
aid mode of action analysis of new drug candidates (Bandow
et al., 2003; Wenzel et al., 2011, 2012, 2013, 2014, 2015b;
Raatschen et al., 2013; Stepanek et al., 2016a,b; Müller et al.,
2016b; Scheinpflug et al., 2017; Saising et al., 2018; Meier et al.,
2019; Wüllner et al., 2019). Radioactive 2D-PAGE should not
be confused with two-dimensional difference gel electrophoresis
(2D-DIGE), which also compares protein expression profiles by
densitometric quantification against a control sample, but is a
fluorescent sample multiplexing and not a metabolic labeling
technique (Minden, 2012).
Radioactive 2D-PAGE has been proven very robust and
potent in the field but has its practical limitations mainly in
terms of equipment needed, handling of and regulations around
radioactive samples, and relatively low throughput. Moreover,
it is not suitable for membrane proteomics, which may be
particularly interesting for AMPs. Gel-free proteomics does
not suffer from these limitations and may be more accessible
to many researchers while providing a similar outcome for
mechanistic studies. The gel-free counterpart of radioactive 2D-
PAGE, in terms of metabolic labeling, is stable isotope labeling
by amino acids in cell culture (SILAC). Here, one culture (e.g.,
the untreated control), is grown in a medium containing a 13C-
labeled amino acid, while another culture, e.g., the antibiotic-
treated sample, is grown on normal medium. This allows pooling
of the samples and quantification in the same run and can
also be done as a pulse experiment to selectively label only
newly synthesized proteins (Snider et al., 2019). Instead of using
mass-labeled amino acids, labeling can also be achieved with
other sources of heavy nitrogen, such as ammonium (Dreisbach
et al., 2008; Wenzel et al., 2014). As with radioactive 2D-
PAGE and 2D-DIGE, SILAC should not be confused with
iTRAQ (isobaric tag for relative and absolute quantitation),
which is not a metabolic labeling but a multiplexing technique
(Unwin, 2010).
Recently, label-free approaches have been heavily employed
for mode of action analysis of antimicrobials (Müller et al., 2016a;
Stepanek et al., 2016b; Gao et al., 2017; Kang et al., 2019; Yuan
et al., 2020). However, these detect differences in protein levels
and not newly synthesized proteins, rather giving insight into
successfully completed stress adaptation rather than acute stress
response. Label-free proteomics ismost powerful when employed
together with a technique that detects the acute stress response,
such as radioactive 2D-PAGE or transcriptomics (Darby et al.,
2014; Müller et al., 2016a; Stepanek et al., 2016b), but can also
effectively aid mode of action analysis by itself (Opoku-Temeng
et al., 2019; Ajdidi et al., 2020).
Metabolomic Profiling
Metabolomics is a comparatively young -omics technique that
has not been extensively employed for mechanistic antibiotic
studies yet. In contrast to genomics, transcriptomics, and
proteomics (Bandow et al., 2003; Tamae et al., 2008; Liu et al.,
2010; O’Rourke et al., 2020), there are no large comparative
metabolomic studies on antibiotic stress yet. However, bacterial
metabolomics has been employed for a variety of applications
including identification of new antibiotics and characterizing
resistance mechanisms (Gao and Xu, 2015; Wu et al., 2015;
Li et al., 2019) and is emerging as a tool in mode of action
studies (Wang et al., 2019; Liu et al., 2020). Metabolomics can
be employed as a more detailed approach to find the affected
metabolic pathway and thus constitute a sensitive alternative
to radioactive and fluorescent precursor incorporation studies,
or as an in-depth analysis of antibiotic effects on the bacterial
metabolism. However, interpreting large metabolomic datasets
requires profound knowledge of the metabolic networks in the
respective organism.
CELL MORPHOLOGY
An alternative or additional starting point to mode of action
analysis can be cell morphology. Many antibiotics, in particular
AMPs, cause distinct defects in cell shape, size, or integrity
that can be observed by both light and electron microscopic
techniques (Friedrich et al., 2000). While examination of cell
morphology alone does normally not identify a mechanism of
action, it provides a good basis for further phenotypical analysis
and the combination of rather simple morphological assays can
be used to effectively map mechanistic classes (Nonejuie et al.,
2013).
Electron Microscopy
A classical method to examine bacterial morphology is
transmission electron microscopy (TEM). TEM has been
frequently employed to study antibiotic effects on bacterial
cells, since it offers unique insight into bacterial ultrastructures
(Friedrich et al., 2000; Sass et al., 2011; Nicolas et al., 2019;
Vazquez-Muñoz et al., 2019). Sample preparation for TEM
involves chemical fixation, dehydration, and contrasting with
metal stains, followed by embedding in resin and ultrathin
sectioning. One limitation of TEM comes into effect when
working with rod-shaped bacteria like E. coli or B. subtilis:
due to the random orientation of bacteria in the resin the
majority of cells is cross-sectioned, which makes it difficult
to assess antibiotic-induced phenotypes. This limitation was
recently overcome by a flat embedding approach, where bacteria
are aligned on an agarose film prior to embedding, resulting in
mostly longitudinally sectioned cells (Wenzel et al., 2019).
Scanning electron microscopy (SEM) is an electron
microscopy technique, which allows inspection of the bacterial
cell surface in great detail but does not allow imaging intracellular
structures. SEM has been successfully employed for antibiotic
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mode of action studies and is particularly interesting for AMPs,
which often cause cell surface defects (Zweytick et al., 2014;
Yang et al., 2017; Nicolas et al., 2019). For SEM, cell samples are
also fixed, dehydrated, and contrasted with a metal stain, but
normally not cut into sections (Kaláb et al., 2008). Environmental
SEM (ESEM) omits the need for critical point drying and enables
imaging of hydrated samples (Collins et al., 1993).
Atomic Force Microscopy
Another form of microscopy that detects surface changes is
atomic force microscopy (AFM). AFM makes use of a small
needle, the cantilever, to scan over a sample and record the
force it encounters when interacting with the sample surface.
This allows the generation of height profiles, measuring of
cell surface stiffness, and detection of cellular content leakage
(Dorobantu and Gray, 2010; Neethirajan and DiCicco, 2014).
AFM is often chosen as a method to examine changes in
bacterial biofilms (Dorobantu and Gray, 2010) and is recently
gaining more attention as a tool to examine bacterial cell
morphology for antibiotic mode of action analysis (Meincken
et al., 2005; Mularski et al., 2016). Moreover, antibiotic-induced
morphological changes measured by AFM can aid identifying
antibiotic-resistant strains (Ierardi et al., 2017) distinguishing
between persister and resister phenotypes (Uzoechi andAbu-Lail,
2020).
Bacterial Cytological Profiling
A relatively new tool for fast mode of action analysis is bacterial
cytological profiling (BCP). This fluorescence light microscopy-
based technique is a combination of different staining techniques
that give a quick overview of major cellular components
(Nonejuie et al., 2013; Lamsa et al., 2016). Using principal
component analysis, antibiotics can be grouped into classes and
new compounds can be rapidly assigned to a mechanistic group.
An expansion of this method, called rapid inhibition profiling
(RIP), allows mapping the target pathway of compounds with
novel targets. This method makes use of proteolytic degradation
of a potential antibiotic target protein to generate a reference
cytological profile, against which new antibiotic candidates
can be compared. This allows a reliable identification of new
mechanisms of action (Lamsa et al., 2016; Peters et al., 2018).
Originally starting with essentially a membrane and DNA
stain, BCP has been further refined and expanded over the years
and has aided a number of mode of action studies (Pogliano
et al., 2012; Nonejuie et al., 2016; Mohammad et al., 2017; Htoo
et al., 2019). Nowadays, it may include a variety of fluorescent
dyes and protein fusions in addition to or in place of the
original membrane and DNA dyes (Araujo-Bazan et al., 2016;
Müller et al., 2016b; Omardien et al., 2018a,b; Saeloh et al.,
2018; Wenzel et al., 2018a). Since a clear definition of bacterial
cytological profiling is missing, the term may be used for a
distinct combination of two or three dyes for high throughput
pathway mapping as well as for comprehensive bacterial cell
biology studies. To get a first glance at cell morphology changes,
the combination of a red membrane dye (typically FM5-95,
FM4-64, or Nile red), a blue DNA dye (typically DAPI), and
phase contrast microscopy has been proven useful (Nonejuie
et al., 2013; Saeloh et al., 2018; Wenzel et al., 2018a). These
dyes are easy to handle, do not require specialized fluorescence
filters, and can be combined with a GFP fusion of interest, for
example the cell division protein FtsZ (Araujo-Bazan et al., 2016).
However, there is a broad palette of fluorescence dyes and protein
fusions available that report on various cellular functions and
components and have been successfully employed in antibiotic
mode of action studies. We will describe a number of such
specialized fluorescence reporters in the following chapter.
CELLULAR COMPONENTS
Once the target pathway or structure has been mapped, the
next step in mode of action analysis is a detailed assessment
of the mechanism of action and identification of the target
structure. While a specific drug-target interaction is normally
always confirmed with purified components in vitro, antibiotics
may have different of additional targets in living cells (Müller
et al., 2016b; Wenzel et al., 2019). A number of in vivo methods
is available to study the effects of antimicrobial compounds on
living bacteria. In the following, we will describe assays that can
be used to assess the effects of AMPs and other antibacterial
molecules on the major components of a bacterial cell.
Outer Membrane
The lipopolysaccharide-rich outer membrane is highly
impermeable and the first line of defense of Gram-negative
bacteria. It is a major intrinsic antibiotic resistance factor and
the main reason why Gram-negative bacteria are much more
resilient to antibiotic attacks than Gram-positive bacteria.
Antibiotics that impair this permeability barrier are urgently
needed (Silhavy et al., 2006) and some AMPs have been shown
to target the outer membrane, most prominently the polymyxins
(Vaara, 1992).
Outer membrane permeability can be assayed with fluorescent
dyes such as 1-N-phenylnaphthylamine (NPN) and 1,8-anilino-
1-napthalenesulfonicacid (ANS). NPN and ANS have a relatively
week fluorescent signal in aqueous solution but exhibit strong
fluorescence in hydrophobic environments like lipid membranes.
These dyes do not penetrate the outer membrane and thus do
not stain intact cells. Upon outer membrane permeabilization
however they can bind to membrane phospholipids leading to an
increased fluorescence signal (Loh et al., 1984; Schved et al., 1994;
Gravel et al., 2017). ANS is sensitive to charge neutralization,
leaving NPN as the dye of choice for polycationic compounds like
many AMPs (Loh et al., 1984).
Similarly, outer membrane permeability can be assayed by
testing the sensitivity to small molecule antibiotics that normally
do not penetrate the outer membrane, but do have a target in
Gram-negative cells (Heesterbeek et al., 2019). In contrast to
fluorescence dyes, this method does not allow quantification of
outer membrane permeabilization. However, using antibiotics of
different molecular weight, the outer membrane pore size can be
estimated. Antibiotics that can be used for this are for example
rhodomyrtone (442.54 g/mol), vancomycin (1449.3 g/mol), and
nisin (3354.07 g/mol).
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Another method to assess the integrity of the outer membrane
is AFM, which reports on cell surface stiffness, which is a direct
measure for outer membrane or, in Gram-positive bacteria, cell
wall integrity and can therefore be employed to measure the
effects of outer membrane-targeting compounds.
Outer membrane proteins can also be used as a proxy to
determine outer membrane integrity. One simple way to do this,
is to isolate outer membrane fractions and perform a Western
blot analysis of outer membrane proteins (Rojas et al., 2018).
Alternatively, proteins can be identified and quantified by mass
spectrometry. In addition to these outer membrane integrity
assays, there are also fluorescence labeling approaches available
to visualize glycans on the outer membrane (Backus et al., 2011;
Siegrist et al., 2015).
Cell Wall
The next barrier after the outer membrane, and the first barrier
in Gram-positive bacteria, is constituted by the peptidoglycan cell
wall. With few exceptions of cell wall-less bacteria, this structure
is essential for bacterial survival. It does not only protect the cell
from mechanical stress, but also prevents it from bursting due
to turgor pressure. Cell wall synthesis is a complex and highly
coordinated process that takes place partly in the cytosol and
partly in the cytoplasmic membrane (Figure 1). Together with
the bacterial ribosome, the cell wall synthesis machinery is the
most successful antibiotic target in the clinic and at the same
time the most common target of AMPs after the cytoplasmic
membrane (Yeaman and Yount, 2003; Schneider and Sahl, 2010).
Moreover, recent studies suggest that the membrane interaction
of AMPs severely disturbs the synthesis of the peptidoglycan
precursor lipid II (Sass et al., 2010; Wenzel et al., 2014; Müller
et al., 2016b).
Due to its utmost clinical relevance and the relatively frequent
discovery of new cell wall-active agents, a broad method
spectrum is available to analyze the effects of compounds on
this pathway, in particular its interaction with lipid II. This
includes various reporter gene assays, in vitro lipid II synthesis,
lipid II binding visualized by thin layer chromatography,
and detection of accumulated lipid II by high performance
liquid chromatography (HPLC), to name only a few standard
techniques (Brötz et al., 1998a; Schneider et al., 2009, 2010;
Schneider and Sahl, 2010; Ling et al., 2015). Taking HPLC-
based detection of cell wall components a step further, recent
studies have succeeded to refine the isolation of cell wall
peptidoglycan and detect glycan strain length and crosslinking,
allowing detailed analysis of cell wall peptidoglycan composition
(Desmarais et al., 2014, 2015; Montón Silva et al., 2018; More
et al., 2019).
A fast assay that can also be used to screen for cell wall
synthesis inhibitors is the AmpC reporter assay (Sun et al., 2002).
In this assay, the beta-lactamase gene ampC and its regulator
ampR from Citrobacter freundii are cloned into E coli. This
system senses accumulated cell wall degradation products and
soluble cell wall precursors and is induced upon inhibition
of peptidoglycan synthesis by a broad spectrum of antibiotics,
not only by beta-lactams. Using an optical density-based beta-
lactamase survival assay, beta-lactamase expression in response
to the antimicrobial compound of interest can be monitored.
However, it has to be noted that this assay does not respond
to every cell wall synthesis inhibitor tested, thus not providing
complete coverage (Sun et al., 2002).
A simple microscopic assay to assess whether incorporation
of cell wall precursors is inhibited is the acetic acid/methanol
fixation (Schneider et al., 2010; Wenzel et al., 2012). In Gram-
positive bacteria, this treatment leads to extrusion of the
protoplast through holes in the cell wall matrix (Figure 1B).
The peptidoglycan layer is a dynamic structure that is constantly
remodeled to accommodate cell growth and division. To this end,
autolytic enzymes constantly break down the cell wall at specific
sites to accommodate incorporation of new cell wall material. If
these holes are not filled because lipid II synthesis is inhibited, a
much higher proportion of cells with membrane extrusions are
observed in the fixation assay. However, deregulation of autolytic
enzymes may have similar effects.
Fluorescently labeled D-amino acids (FDAAs) have been a
major breakthrough in the field, since they for the first time
allowed the direct visualization of active incorporation of cell
wall precursors into living bacterial cells under the microscope
(Kuru et al., 2015; Hsu et al., 2017). FDAAs mimic the D-amino
acids in the peptide side chain of the peptidoglycan precursor and
are incorporated into the cell wall by penicillin-binding proteins
(HADA) or L-D-transpeptidases (NADA) (Figure 2) (Montón
Silva et al., 2018). Incorporation of FDAAs into the cell wall does
not appear to be toxic for bacteria. Since their original discovery,
new FDAAs have been designed in different fluorescent colors,
making them readily available for co-localization experiments
(Hsu et al., 2017). However, the different FDAAs have their
advantages and disadvantages. For example, HADA is sensitive
to photobleaching, while NADA requires higher concentrations
to achieve a satisfactory fluorescence signal, and TDL, a red-
fluorescing FDAA, only weakly stains E. coli (Kuru et al., 2015).
A different way of visualizing the effects of antibiotics on
cell wall precursors, it sortase-mediated fluorescence labeling of
lipid II, which generally works well for Gram-positive species
(Nelson et al., 2010). While incorporation efficiency of FDAAs
is likely inhibited by antibiotics, sortase-mediated labeling will
be largely unaffected (Sugimoto et al., 2017). Sortase is a
membrane-bound protease that cleaves a signal peptide sequence
off transmembrane proteins. This can be used to cleave a
fluorescence tag, which can be biotin, azide, or a fluorescent
chromophore (Nelson et al., 2010), from a transmembrane
protein. This tag can then react with lipid II, producing a labeled
version of the precursor on the membrane surface (Figure 3). If
an antibiotic interferes with cell wall synthesis, this will lead to
mislocalization or clustering of the labeled molecule.
Another way to visualize cell wall synthesis components is
the labeling of antibiotics with the fluorescence tag 4,4-difluoro-
4-bora-3a,4a-diaza-s-indacene (BODIPY). BODIPY is a very
common fluorescence tag that can be easily conjugated with a
number of biomolecules, including antibiotics that inhibit cell
wall synthesis. Vancomycin-BODIPY (Van-FL) and penicillin-
BODIPY (bocillin) are commercially available. Van-FL binds to
the D-Ala-D-Ala motif of lipid II and has been successfully
used to visualize lipid II (Pogliano et al., 2012; Schirner et al.,
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FIGURE 1 | Peptidoglycan synthesis as antibiotic target. (A) Overview of peptidoglycan synthesis in S. aureus and antibiotics targeting this pathway (modified from
Schneider and Sahl, 2010). Peptidoglycan synthesis is a common target of peptide antibiotics. With the exception of tunicamycin and fosfomycin, all antibiotics in this
figure are peptide-based. (B) Acetic acid/methanol fixation of B. subtilis. Inhibition of cell wall synthesis leads to extrusion of the protoplast through breaches in the
peptidoglycan layer.
2015). Bocillin binds to penicillin-binding proteins (PBPs) and
can be used for visualizing the localization of these proteins or
for competition experiments with other PBP inhibitors. Since
bocillin does not recognize all PBPs, BODIPY fusions to other
PBP inhibitors can be employed to distinguish between PBP
subpopulations (Stone et al., 2018).
Cytoplasmic Membrane
The cytoplasmic membrane is the target of the majority of
AMPs. A plethora of biophysical techniques are available to
assay the parameters of model membranes and such assays have
been excessively used to characterize the membrane interactions
of AMPs in vitro. However, the true complexity of bacterial
membranes cannot be mimicked, since not only the composition,
but also the physicochemical properties vary drastically from
species to species, between different growth conditions, between
media, and growth phases. It has become apparent that model
membrane studies are not enough to truly describe the complex
nature of AMP-membrane interactions, the most prominent
example being daptomycin (Pogliano et al., 2012; Müller et al.,
2016b; Gray and Wenzel, 2020a; Grein et al., 2020). This
realization together with the growing interest in microbial
membrane architecture (Jones et al., 2001; Lopez and Kolter,
2010; Barák and Muchová, 2013; Bramkamp and Lopez, 2015;
Strahl and Errington, 2017) has prompted the development of
a variety of in vivo techniques to analyze membrane physiology
in living bacteria. The amount of available techniques would go
beyond the scope of this review, but we will describe a number
of relatively easily accessible techniques that are well-suited for
mode of action analysis of AMPs.
Membrane Composition
Bacterial membranes are complex mixtures of roughly equal
parts of lipids and proteins. The lipid composition of bacterial
membranes is far from static and varies depending on a variety of
factors. Thus, bacteria readily adapt theirmembrane composition
under antibiotic stress (Fränzel et al., 2010; Saeloh et al., 2018).
The membrane composition of bacteria can be analyzed in
different ways. Head group composition can be easily analyzed
using thin layer chromatography (Pogmore et al., 2018), a
technique that does not require expensive instrumentation or
access to mass spectrometry facilities. Fatty acid composition
can be measured by gas chromatography (Saeloh et al., 2018).
Lipidomics can also be performed bymass spectrometry allowing
sensitive detection of lipid species, detection of head groups and
fatty acids, and fingerprinting [e.g., to identify bacterial species
according to their lipid profile (Fränzel et al., 2010; Rezanka et al.,
2015; Hewelt-Belka et al., 2016)].
Antimicrobial compounds may bind to a specific lipid
species. One example for this is daptomycin, which binds
to phosphatidylglycerol lipids and prefers fluid membrane
environments (Hachmann et al., 2011; Müller et al., 2016b).
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FIGURE 2 | Incorporation of fluorescent cell wall labels. (A) Structures of different fluorescently labeled amino acids (FDAAs) with different spectral properties (HADA:
blue, NADA: green, YADA: yellow, TADA: red) (Kuru et al., 2015; Hsu et al., 2017). (B) FDAAs mimic the peptide side chain of the peptidoglycan precursor and are
incorporated into the cell wall by bacterial enzymes (modified from Hsu et al., 2017). (C) Incorporation of fluorescent tags into the peptidoglycan layer by
sortase-mediated labeling. The fluorescent tag is coupled to a membrane protein through a linker that contains a signal peptide sequence that is cleaved by the
sortase enzyme. The free tag can then bind lipid II through a nucleophilic attack. This results in a tagged lipid II, which is incorporated into the cell wall by
penicillin-binding proteins (Hendrickx et al., 2011).
Mutant analysis is a powerful tool to investigate such preferences.
For example, B. subtilis mutants lacking specific head groups,
such as phosphatidylethanolamine or lysyl-phosphatidylglycerol
and mutants with altered membrane fluidity have been
established and some of them have been used for antibiotic mode
of action analysis (Salzberg and Helmann, 2008; Mercier et al.,
2012; Saeloh et al., 2018; Gohrbandt et al., 2019). However, some
lipid species are essential. For example, in contrast to E. coli
phosphatidylglycerol-free B. subtilis cells are not viable. In such
cases depletion strains can be used (Murray and Koh, 2014).
General Membrane Dyes
Several fluorescence dyes are available to visualize cell
membranes under the microscope. Some of them are specific
for a certain membrane parameter, while others are rather
unselective, general membrane dyes. The latter ones are a good
tool for simple bacterial cytological profiling experiments and
co-localization with membrane proteins or cell wall labels.
For bacteria, mainly red and green fluorescence dyes are used
(Table 3). MitoTracker Green (MTG) is a very bright green
membrane dye. It provides an excellent signal-to-noise ratio and
very good contrast for high resolution techniques like structured
illumination microscopy (SIM) (Saeloh et al., 2018). However,
prolonged exposure to MTG is toxic for bacteria and leads to
artifacts. MTG also stains the forespore membrane in B subtilis
(Schneider et al., 2007).
Nile red is a relatively photostable bright red-fluorescent
dye. It is easy to handle and also provides a good contrast.
However, the dye readily adsorbs to glass cover slips resulting
in a high background. Coating the cover slips with poly-L-
dopamine resolves this issue and allows using the dye for
SIM (te Winkel et al., 2016; Saeloh et al., 2018). Nile red is
often used for co-localization studies with GFP-labeled proteins.
Yet, its brightness and broad excitation and emission make it
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FIGURE 3 | Assays for membrane depolarization. (A) Membrane depolarization assay with DisC3(5). This self-quenching dye inserts into polarized membranes and is
released upon depolarization leading to an increased fluorescent signal. (B) Membrane potential assay with DiBAC4(3). This dye does not insert into polarized
membranes and is only self-quenching at very high concentrations. Upon depolarization it inserts into the membrane resulting in an increased fluorescence signal (te
Winkel et al., 2016). (C) Depolarization assay with the GFP-MinD reporter strain. MinD normally localizes at the cell poles and the cell division plane. Membrane
depolarization, here by tyrocidine A, leads to disturbance of this regular pattern and a spotty GFP signal over the whole cell membrane and partial dislocation of the
protein into the cytosol (Strahl and Hamoen, 2010).
prone to bleeding into other channels (Ohsaki et al., 2010).
Like MTG, Nile red is toxic upon prolonged exposure and
additionally enhances phototoxicity, making it unsuitable for
timelapse microscopy.
Alternatives to Nile red are the red-fluorescent general
membrane dyes FM5-95 and FM4-64. They are less bright than
Nile red and strongly adsorb to glass cover slips. While dopamine
coating prevents this well enough for normal microscopy, these
dyes do normally not provide sufficient contrast for SIM. They
are better suited for co-localization studies due to lower bleed
through and are not toxic for bacterial cells, making them the
dyes of choice for timelapse experiments (Pogliano et al., 2012;
Müller et al., 2016b; Wenzel et al., 2018a).
All of these dyes, like most dyes and proteins, will transition
into the fluid phase upon phase separation (Müller et al., 2016b;
Scheinpflug et al., 2017; Saeloh et al., 2018; Gohrbandt et al.,
2019), making them a robust tool to assess membrane phase
separation induced by membrane-active AMPs (Scheinpflug
et al., 2017).
Membrane Pores
AMPs are typically thought to form pores in bacterial
membranes. While this is certainly the case for some AMPs,
there are many others that affect the membrane in different ways
(Wenzel et al., 2014, 2018a; Müller et al., 2016b; Scheinpflug
et al., 2017). The common pore models of AMP action are mainly
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TABLE 3 | Selection of fluorescence dyes applied in mode of action experiments.
Dye Reports on Example study on bacteria
NPN Outer membrane permeability Loh et al., 1984
ANS Outer membrane permeability Schved et al., 1994
Bocillin Penicillin-binding proteins Pogliano et al., 2012
Van-FL Lipid II Pogliano et al., 2012
HADA Sites of active cell wall synthesis Schirner et al., 2015
NADA Sites of active cell wall synthesis Montón Silva et al., 2018
Mitotracker green (MTG) General membrane dye Saeloh et al., 2018
Nile red General membrane dye Saeloh et al., 2018
FM5-95 General membrane dye Müller et al., 2016b
FM4-64 General membrane dye Pogliano et al., 2012
NAO Negatively charged phospholipids Pogmore et al., 2018
DiIC12 Fluid membrane microdomains Wenzel et al., 2018b
DPH Membrane fluidity Bessa et al., 2018
Laurdan Membrane fluidity Wenzel et al., 2018b
DiSC3(5) Membrane potential te Winkel et al., 2016
DiBAC4(3) Membrane potential te Winkel et al., 2016
APG-2 Potassium flux Saeloh et al., 2018
Propidium iodide Pores Jiang et al., 2019
Sytox green Pores Barns and Weisshaar, 2013
BCECF pH Strahl and Hamoen, 2010
Resazurin Respiratory chain activity Saeloh et al., 2018
INT Respiratory chain activity Dutton et al., 1983
CTC Respiratory chain activity Rodriguez et al., 1992
CellRox Reactive oxygen species Wenzel et al., 2013
Oxyburst green Reactive oxygen species Surewaard and Kubes, 2017
DCFH-DA Reactive oxygen species Arakha et al., 2015
DAPI DNA Nonejuie et al., 2013
SYTO9 DNA Krychowiak et al., 2018
SYTO RNAselect RNA Bakshi et al., 2014
This list is not exhaustive and only includes dyes that have been used for antibiotic mode of action studies in bacteria. Note that some of these dyes have several derivatives covering
different wavelengths (e.g., SYTO dyes) or having different membrane-penetrating properties (e.g., APG dyes).
derived from in vitro assays and confirmation of such results
in vivo is pivotal. Several tools are available for this purpose
(Table 3).
A simple method to assess the formation of large pores is
to monitor efflux of proteins, for example intracellular GFP
(Yoneyama et al., 2009). This efflux can also be followed using
timelapse microscopy visualizing the attack of AMPs on bacterial
cells in a time-resolved manner (Barns and Weisshaar, 2016).
One of the most common pore assays is propidium
iodide staining, in combination with a SYTO9 counterstain
also marketed under the name BacLight Live/Dead assay.
Both dyes bind to DNA, but only SYTO9 can cross intact
membranes resulting in green-fluorescent cells. If the membrane
is perforated, and given that pores are big enough, propidium
iodide can enter resulting in red-fluorescent cells. This assay can
be usedmicroscopically, but is also very popular for fluorescence-
activated cell sorting (FACS) (Freire et al., 2015; Patra et al.,
2015).
A similar stain is Sytox green, a green-fluorescent dye that
can only enter cells through membrane pores. Sytox green has
been successfully employed for real-time monitoring of pore
formation by AMPs (Barns and Weisshaar, 2013; Rangarajan
et al., 2013). Sytox is also available in other colors (e.g., red
and deep red), allowing combination with other dyes. Similarly,
the membrane-permeable SYTO dyes, which are often used as
counterstains, are available in variants covering the full spectrum
of visible light.
Leakage of smaller intracellular molecules like amino acids
or nucleotides can be measured by HPLC (Wenzel et al.,
2015b; Ye et al., 2018). Smaller, ion-conducting pores can be
monitored with different techniques. Commonly, potassium-
selective electrodes are employed (Wenzel et al., 2012; Münch
et al., 2014). The advantage of measuring potassium with an
ion-selective electrode is that it can be done in a time-resolved
manner. However, AMPs may adsorb to the electrode surface
causing measurement artifacts or even damaging the electrode.
Another limitation is the ion selectivity itself, since a compound
may as well be an ionophore selective for another ion. This can be
assayed with total ion analysis, also referred to as ionomics, which
is typically measured by inductively coupled atomic emission
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spectroscopy (ICP-AES) or ICP mass spectrometry (ICP-MS)
(Baxter, 2010; Wenzel et al., 2014; Müller et al., 2016b).
Another method to measure ions are ion-sensitive dyes, such
as Asante potassium green (APG-2) or Asante sodium (natrium)
green (ANG-2). APG-2 has been successfully employed for
measuring potassium efflux from B. subtilis cells treated with
antibiotics (Saeloh et al., 2018). Both APG-2 and ANG-2 are
available as membrane-permeable acetoxymethyl (AM) ester
for intracellular measurements and as membrane-impermeable
tetramethylammonium (TMA) salt for extracytoplasmic
measurements. Similarly, proton concentrations can be
measured intra- and extracellularly using the pH-sensitive
dye 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein
(BCECF), which also comes as AM and TMA version (Strahl and
Hamoen, 2010).
The combination of cytosolic GFP leakage, fluorescent pore
stains, leakage of small cellular molecules, and measuring ion
permeability allows insight into pore size.
Membrane Potential
Pore formation, regardless of large or small, will result in
membrane depolarization. However, depolarization can be
achieved without the noticeable presence of pores. Thus,
impaired respiration may diminish the proton gradient and/or
small transient ion currents may contribute to depolarization.
Such effects may not be captured in pore assays. Therefore,
the membrane potential should always be measured in
addition to leakage assays. Two fluorescent dyes are well-
established for membrane potential measurements in bacteria,
3,3′-dipropylthiadicarbocyanine iodide (DiSC3(5)) and bis-
(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC4(3))
(Figure 3).
DiSC3(5) is a self-quenching dye that inserts into polarized
membranes (Figure 3A). It is released upon depolarization
leading to an increased fluorescent signal in spectroscopic assays
(te Winkel et al., 2016). DiSC3(5) is a sensitive dye and captures
small potential changes as well as transient depolarization
with accuracy. Using the potassium ionophore valinomycin,
the measurements can be calibrated allowing quantitative
information about the membrane potential (te Winkel et al.,
2016). DiSC3(5) can be used microscopically allowing single cell
analysis and assessing heterogeneity in the cell population. It is
a far-red dye and thus compatible with GFP fusions and most
other dyes commonly used in bacterial cell biology. However,
prolonged exposure to DiSC3(5) is toxic for bacterial cells
preventing its use in timelapse microscopy (te Winkel et al.,
2016). While this dye does not bind to glass cover slips, it
does interact with polydimethylsiloxane, a common material for
microfluidic devices (te Winkel et al., 2016).
DiBAC4(3) is an alternative to DiSC3(5) with a slightly
different mechanism (Figure 3B). This dye does not insert into
polarized membranes and is only self-quenching at very high
concentrations. It can only insert into depolarized membranes,
which results in an increased cellular fluorescence signal due
to the locally higher dye concentration (te Winkel et al., 2016).
It is used for both membrane potential measurements and cell
viability assays (Jepras et al., 1997). DiBAC4(3) is not toxic to
bacteria during prolonged incubation and is therefore suitable
for timelapse microscopy (te Winkel et al., 2016). However, the
dye binds strongly to glass surfaces, which can be prevented by
poly-L-dopamine coating (te Winkel et al., 2016).
A simple and quick experiment to check for membrane
depolarization is the MinD delocalization assay. MinD is a
protein involved in the regulation of cell division site positioning
in rod-shaped bacteria. It binds to the cell membrane with an
amphipathic alpha-helix motif and localizes at the cell poles
and the cell division site. This localization is severely disturbed
upon depolarization (Strahl and Hamoen, 2010). In B. subtilis,
depolarization leads to a spotty localization pattern and partial
dissociation of the protein from the membrane into the cytosol
(Figure 3C). In E. coli, MinD oscillates from pole to pole, which
can be easily observed by timelapse microscopy. Dissipation of
the membrane potential abolishes this oscillation (Strahl and
Hamoen, 2010). The cell division protein FtsA and the cell shape
determining protein MreB are also delocalized upon membrane
depolarization, FtsA being released from the membrane into the
cytosol and MreB forming clusters at the cell membrane (Strahl
and Hamoen, 2010). However, MinD is the most popular proxy
for dissipation of the membrane potential and has been used in
a number of studies (Chimerel et al., 2012; Eun et al., 2012; Foss
et al., 2013; Wenzel et al., 2015a).
In E. coli, it is also possible to measure the membrane
potential directly by patch clamp of giant spheroplasts generated
from cells treated with the cell septation inhibitor cephalexin
(Sun et al., 2014; Kikuchi et al., 2015). Cephalexin selectively
binds to PBP4, a penicillin-binding protein involved in septation
(Kocaoglu and Carlson, 2015). This results in a septum-free,
elongated phenotype suitable for generating giant spheroplasts
for patch clamp.
It has to be noted that microscopy slides coated with
poly-lysine, which are sometimes used to immobilize cells,
already cause depolarization of bacterial cells. Such slides should
never be used for bacterial studies, neither for depolarization
assays nor any other experiment on live cells, since membrane
depolarization causes a plethora of pleiotropic effects that cannot
be distinguished from antibiotic effects (Strahl and Hamoen,
2010).
Membrane Fluidity
Membrane fluidity has recently emerged to play a central role in
the mechanism of action of antibiotics and AMPs (Hachmann
et al., 2009; Strahl et al., 2014; Müller et al., 2016b; Scheinpflug
et al., 2017; Omardien et al., 2018b; Wenzel et al., 2018a).
Membrane fluidity is essentially defined as the viscosity of the
cell membrane and can be affected by a number of factors, such
as membrane composition, proteins, or temperature. It is difficult
to define the overall fluidity of a biological membrane and there
is no method to measure this directly. Instead, the complex
factors contributing to membrane fluidity are best described
by a number of assays that report on each of these factors
separately to obtain a differentiated picture of the biological
membrane system.
Membrane composition is a crucial factor for fluidity that
bacteria can adapt according to the environmental conditions
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(Zhang and Rock, 2008). In B. subtilis, which has more than
90% branched-chain fatty acids, membrane fluidity is mainly
controlled by the ratio of iso and anteiso-branched-chain fatty
acids. Fast stress adaptation is additionally achieved by the
degree of fatty acid desaturation (Beranová et al., 2008; Kingston
et al., 2011). These ratios can be assayed by lipid analysis as
described earlier.
Membrane fluidity crucially affects the movement of proteins
within the lipid bilayer. The diffusion of membrane proteins
can therefore be used as a measure for overall membrane
fluidity. Thus, fluorescence recovery after photobleaching
(FRAP) can be employed to assay this membrane parameter.
FRAP is a fluorescence microcopy method that uses laser-
based photobleaching of a small area of a cell, usually a
cell pole. Recovery of the fluorescence signal by diffusion
of fluorophores into the previously bleached area can be
observed by timelapse microscopy. When this experiment is
performed with a fluorescently labeled membrane protein, the
fluorescence recovery rate gives a measure for membrane fluidity
(Devkota and Pilon, 2018). FRAP is one of the most direct
techniques to monitor membrane fluidity. However, in bacteria
the photobleached region is quite large compared to the cell
size, which does not allow precise measurements of specific
membrane domains. Thus, it can only be used as a measure for
general membrane fluidity over the whole cell membrane.
Fluorescence dyes are another alternative to measure
membrane fluidity. 1,6-diphenyl-1,3,5-hexatriene (DPH) is a
hydrophobic trans-polyene that inserts into the membrane
bilayer and orientates itself parallel to the fatty acid chains
(Los and Murata, 2004). DPH is a fluorescence polarization
probe. Its rotational mobility directly depends on membrane
fluidity, allowing DPH polarization to be used as a direct measure
of this membrane parameter (Fox and Delohery, 1987). DPH
has been employed to assess membrane fluidity in antibiotic-
treated bacteria including E. coli, B. subtilis, and Staphylococcus
aureus (Bessa et al., 2018; Gohrbandt et al., 2019). DPH
delivers robust spectroscopic data but cannot be visualized under
the microscope.
An alternative to DPH is the fluidity-sensitive membrane
dye 2-dimethylamino-6-lauroylnaphtalene, commonly known as
laurdan. Detection of membrane fluidity by laurdan is based
on a fluorescence emission shift depending on the amount of
water molecules that surround the probe. Thus, laurdan is not
a direct measure of membrane viscosity, but indicates lipid head
group spreading and fatty acid chain mobility, which are crucial
factors for the fluidity of biological membranes (Parasassi and
Gratton, 1995; Sanchez et al., 2007). Laurdan is excited at 350 nm
and emission is recorded at 460 and 500 nm. Calculating the
generalized polarization [GP = (I460 – I500)/(I460 + I500)] gives
a measure for membrane fluidity. Laurdan GP can be measured
both spectroscopically andmicroscopically (Figure 4). A detailed
protocol for laurdan-based fluidity measurements in bacteria has
been published recently (Wenzel et al., 2018b). Both DPH and
laurdan can also be used in model membrane systems, which can
be a useful as a control to discern direct from indirect antibiotic
effects (Tyteca et al., 2003; Saeloh et al., 2018; Wenzel et al.,
2018b).
Another parameter that influences membrane fluidity is
membrane thickness, with fluid membranes being thinner than
rigid bilayers (Reddy et al., 2012; Karabadzhak et al., 2018).
AMPs can induce both, membrane thinning and thickening
(Grage et al., 2016). Biophysical methods to measure membrane
thickness of model membranes include solid state 2H-NMR and
grazing incidence small X-ray scattering (GISAXS) (Grage et al.,
2016). However, methods tomeasuremembrane thickness in vivo
are scarce. It has been proposed that pore-forming alpha-helical
peptides of different length can be employed as “molecular rulers”
to measure membrane thickness in vivo (Grau-Campistany et al.,
2015). While this is a very interesting approach, its suitability for
determining antibiotic-induced changes in membrane thickness
remains to be evaluated. However, it can be expected that the
combined effects of the ruler peptides and the antimicrobial
molecule of interest may affect the results. It would also not be
suited for any type of pore-forming compound, which would
interfere with the readout of the assay, being either cell viability
or membrane permeability (Grau-Campistany et al., 2015).
Membrane thickness can be qualitatively assessed in
vivo with the fluorescence dye 1,1′-didodecyl-3,3,3′,3′-
tetramethylindocarbocyanine perchlorate (DiIC12). However,
DiIC12 is rather a fluid membrane domain dye than an accurate
reporter for membrane thickness (Figure 4).
Membrane Domains
Bacterial membranes are heterogenous lipid mixtures and
contain different types of lipid domains. DiIC12 stains fluid
membrane domains based on its preference for thinner
membrane regions, which is determined by its short 12C
hydrocarbon tail (Baumgart et al., 2007; Zhao et al., 2013). Rod-
shaped bacteria that grow through lateral expansion of the cell
wall possess fluid membrane domains that harbor the lateral cell
wall synthesis machinery. These domains are termed regions of
increased fluidity (RIF). In B. subtilis and E. coli DiIC12 displays
a clear preference for RIFs (Figure 4) (Strahl et al., 2014; Oswald
et al., 2016). In the cocci S. aureus and Streptococcus pneumoniae,
which do not possess RIFs as such, DiIC12 still produces a
heterogenous membrane stain suggesting that these bacteria have
fluid lipid domains as well (Saeloh et al., 2018; Gray and Wenzel,
2020a). It has to be noted that at least in B. subtilis RIFs can
only be observed in exponentially growing cells. In stationary
phase cells, DiIC12 staining results in a smooth membrane stain
(Wenzel et al., 2018a). A detailed protocol for this fluid lipid
domain stain has been published recently (Wenzel et al., 2018b).
While analogous dyes with longer hydrocarbon tails exist (e.g.,
DiIC18), they do not seem to stain rigid membrane domains
(Strahl et al., 2014). Currently, no dye exists that displays
affinity for thicker or more rigid membrane domains in bacteria.
However, larger rigid domains can be visualized with laurdan
(Scheinpflug et al., 2017). Also, the absence or strong reduction
of the signal of a fluorescent membrane stain or protein may
indicate a gel-phase membrane domain. However, one has to
keep in mind that gel-phase domains are thought not to exist
in bacterial membranes under normal conditions and only occur
through intense membrane stress (Wenzel et al., 2018a).
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FIGURE 4 | Tools for microscopic examination of membrane domains of different fluidity. (A) Laurdan is a fluorescent membrane dye that exhibits a fluidity-dependent
fluorescence emission shift (schematic not to scale). (B) Laurdan can be used in spectroscopic assays allowing recording of the kinetics of overall membrane fluidity
changes. The cyclic beta-sheet peptide tyrocidine A causes rapid membrane rigidification. (C) Laurdan can also be visualized under the microscope and a GP scale
can be created using ImageJ. Tyrocidine-induced membrane domains appear much more fluid (red) than the rest membrane (green). (D) DiIC12 preferentially inserts
into fluid membrane environments and is therefore well-suited to detect RIFs and other fluid membrane domains (schematic not to scale). (E) Treatment with tyrocidine
A disturbs the distribution of RIFs and induces their fusion into large fluid domains. (F,G) Flotillins are reporters for rigid membrane domains (lipid rafts). Delocalization
of FloA (F) and FloT (G) by tyrocidine A indicates that this peptide affects membrane domains.
Certain membrane proteins can be used as proxies for
membrane domains of different fluidity. Thus, the lipid II
synthase MurG and the phospholipid synthase PlsX localize in
RIFs in exponentially growing B. subtilis (Müller et al., 2016b).
MreB also co-localizes with RIFs both in B. subtilis and E. coli,
but less strictly than MurG and PlsX (Strahl et al., 2014; Oswald
et al., 2016). In contrast, flotillins are proteins that are thought
to be associated with and stabilize lipid rafts, may be used as
proxies for rigid membrane domains (Lopez and Kolter, 2010;
Bach and Bramkamp, 2013; Wagner et al., 2020). In B. subtilis
known flotillins are the integral membrane protein FloA and the
peripheral FloT (Figure 4) (Dempwolff et al., 2012). However,
a recent study has shown evidence that these proteins may be
associated with fluid rather than rigid domains (Zielińska et al.,
2020), challenging the established paradigm and questioning the
use of flotillins as raft reporters in bacteria.
Many membrane-active compounds including several AMPs
affect the distribution of membrane domains. RIFs seem to be
very sensitive to this, which makes sense since membrane areas
with higher fluidity better accommodate molecules than less fluid
membranes. A common phenotype appears to be the fusion of
RIFs leading to accumulation of lipid dye in these antibiotic-
induced fluid domains (Omardien et al., 2016; Saeloh et al., 2018;
Wenzel et al., 2018a). This does not only affect DiIC12, but
most membrane dyes includingMTG, Nile red, FM5-95, laurdan,
and DiSC(3)5, as well as many membrane proteins (Müller
et al., 2016b; te Winkel et al., 2016; Saeloh et al., 2018; Wenzel
et al., 2018a). However, a similar phenotype can be observed for
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membrane invaginations. Typically, invaginations are too small
to be seen by wide-field microscopy, but the double or multiple
membrane layers will result in a locally increased fluorophore
concentration. To distinguish between a fluid domain and an
invagination, structured illumination microscopy (SIM) can be
employed (Mercier et al., 2013; Saeloh et al., 2018; Wenzel et al.,
2018a). Alternatively, a GFP fusion to the B. subtilisAtpA protein
can be used (Johnson et al., 2004). This ATP synthase subunit
does not accumulate in fluid membrane domains, but due to
its uniform distribution over the membrane does accumulate
in membrane invaginations (Saeloh et al., 2018; Wenzel et al.,
2018a).
Apart from membrane domains of different fluidity, lipid
domains characterized by specific head group species have
been proposed, most prominently cardiolipin domains. These
domains have been visualized with the positively charged
membrane dye nonyl acridine orange (NAO), which stains
negatively charged phospholipids (Mileykovskaya and Dowhan,
2009). However, this well-established concept has recently been
challenged, when Pogmore et al. showed that these domains are
in fact artifacts caused by stress inflicted through the staining
procedure. In fact, domains appeared in a B. subtilis strain fully
devoid of cardiolipin, when the standard staining protocol was
used. In contrast, the wild type strain stained with a stress-
free protocol showed no accumulation of the dye in domains
(Pogmore et al., 2018).
Membrane-Bound Processes
One crucial component of bacterial membranes is often neglected
in mode of action studies of AMPs, namely membrane-
bound proteins, which make up about half of the mass
of the cytoplasmic membrane. While many AMPs disrupt
membrane integrity at high peptide to lipid ratios, their minimal
inhibitory and bactericidal concentrations are often far below the
concentrations needed for efficient membrane permeabilization
(Gray and Wenzel, 2020a). It is therefore likely that effects on
essential membrane-bound processes caused by perturbations of
membrane fluidity or architecture are responsible for growth
inhibition and cell death at these concentrations. Moreover, more
and more membrane-active molecules are found that do not kill
bacteria by membrane permeabilization but by interfering with
the coordination of membrane-bound processes (Sass et al., 2010;
Wenzel et al., 2014, 2018a; Wilmes et al., 2014; Jahn et al., 2015;
Scheinpflug et al., 2017; Saeloh et al., 2018).
One extensive method to assess the effect of antibiotics
on membrane proteins is what could be called extended
bacterial cytological profiling. BCP is often used as a relative
high-throughput assay for mode of action classification and
antimicrobial susceptibility testing that relies on the combination
of typically two to four key reporters (Nonejuie et al., 2013;
Araujo-Bazan et al., 2016; Lamsa et al., 2016; Quach et al.,
2016). However, it can also be used in more extensive studies by
examining a broad panel of GFP fusions, often in combination
with some of the dyes discussed above (Müller et al., 2016b;
Omardien et al., 2018a; Wenzel et al., 2018a). GFP fusions can
be employed for this approach in two ways: to determine which
processes are affected by an antibiotic and as reporters for certain
membrane parameters [e.g., MinD for membrane depolarization
(Strahl and Hamoen, 2010; teWinkel et al., 2016)]. Table 4 shows
a selection of GFP fusions commonly employed for antibiotic
mode of action studies in B. subtilis.
The localization of a protein is crucial for its correct function
making BCP is a reliable assay to map affected processes.
However, it does not yield information about the degree of
inhibition. Therefore, it may be necessary to additionally test
the functionality of a membrane-bound process of interest. The
most commonly affected pathways are cell wall synthesis (assays
described above) and the respiratory chain.
Activity of the respiratory chain can be measured in
different ways. One option is the dye resazurin, which can be
reduced to the differently colored resorufin. The probe is an
indicator of an active respiratory chain since the reduction to
resorufin is proportional to aerobic respiration (González-Pinzón
et al., 2012). Resazurin can also be used in isolated inverted
membrane vesicles and is compatible with both calorimetric and
fluorescence detection. Alternatively, tetrazolium dyes can be
used. For example, the colorless 5-cyano-2,3-ditolyl tetrazolium
chloride (CTC) can be reduced to a bright red-fluorescing CTC-
formazan through an active electron transport chain (Rodriguez
et al., 1992). A similar dye that is employed for this purpose is 2-
(p-iodophenyl)-3-(p-nitrophenyl)-5-phenyl tetrazolium chloride
(INT) (Dutton et al., 1983). Both CTC and INT are suitable for
fluorescence spectroscopy and microscopy.
Inhibition of the respiratory chain typically leads to depletion
of cellular ATP levels. This can be measured with commercially
available chemiluminescence assays (Wenzel et al., 2014;
Scheinpflug et al., 2017), or detected by HPLC or mass
spectrometry (Dudley and Bond, 2014; Ye et al., 2018).
Several other membrane-bound processes may be inhibited
by AMPs, including cell division, membrane and teichoic acid
synthesis, protein secretion, nutrient uptake systems, virulence,
or motility. Listing possible assays for each membrane-bound
process would go beyond the scope of this article but it is good
to be aware that disruption of membrane lipids can have a
plethora of effects on membrane proteins, from almost universal
protein delocalization to very specific effects on a small number
of proteins (Müller et al., 2016b; Wenzel et al., 2018a; Gray and
Wenzel, 2020b).
Proteins
The direct interaction of antibiotics with specific protein targets
is typically confirmed by in vitro binding and activity assays.
However, this requires that a candidate protein is already known,
which is normally only the case for derivatives of known
antimicrobial compounds. Finding a candidate protein target
from scratch can be difficult and in the following we will
describe a selection of methods that help identify candidate
target proteins.
Bacterial cytological profiling can be employed for
intracellular protein targets, since a disruption of their
localization pattern is indicative of an interruption of
the respective pathway (Figure 5). Several GFP fusions to
intracellular targets have been used for this purpose (Table 4).
Inhibition of one specific protein can also affect the functionality
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TABLE 4 | Proteins commonly used for bacterial cytological profiling and their localization in B. subtilis (Müller et al., 2016b; Saeloh et al., 2018; Wenzel et al., 2018a).
Protein Protein function Reporter for Localization
HbsU Regulation of nucleoid compaction Chromosome compaction
ParB Chromosome positioning before septation DNA replication
PolC Alpha-subunit of the DNA polymerase III DNA replication
DnaN Beta-subunit of the DNA polymerase III DNA replication and repair
RecA Homologous recombination and DNA repair DNA damage
RpoC Beta-subunit of the RNA polymerase RNA synthesis
RpsB Ribosomal protein Protein synthesis
PgsA Biosynthesis of phospholipids Phospholipid synthesis
PlsX Phospholipid synthase Phospholipid synthesis
FloA Flotillin Membrane domains
FloT Flotillin Membrane domains
SdhA Succinate dehydrogenase Membrane-bound energy generation
AtpA ATP synthase Membrane invagination
DivIVA Cell division regulation Cell division
MinD Cell division regulation Cell division
FtsA Membrane anchor of the cell division protein FtsZ Cell division
FtsZ Major cell division protein, forms the Z-ring Cell division
MreB Cell shape-determining protein Cytoskeleton
MreC Cell shape-determining protein Cytoskeleton
MreD Cell shape-determining protein Cytoskeleton
MurG Lipid II synthase Cell wall synthesis
MraY Lipid I synthase Cell wall synthesis
PBP2B Penicillin-binding protein 2B Cell wall synthesis
PonA Penicillin-binding protein 1A/1B Cell wall synthesis
FtsW Peptidoglycan glycosyltransferase Cell wall synthesis
and localization of its interaction partners. While this makes
BCP a great tool to study the effects of a compound in detail, it
rarely identifies the target protein by itself and typically needs
follow-up studies.
A more specific way of identifying protein targets is based
on the detection of protein stability changes upon binding of
an antibiotic ligand. Typically, binding of a ligand stabilizes
the target protein and protects it from proteolytic degradation
(Lomenick et al., 2009). This can be exploited for target
identification by globally mapping protein stability with and
without addition of the antibiotic compound. Proteins that
display stability changes constitute potential targets. This method
can, in principle, be performed on both cell extracts and whole
cells and detection methods of the stability shift range from
simple SDS-PAGE to advanced mass spectrometry techniques
(Mateus et al., 2017).
Several other methods based on the principle of ligand-
mediated protein stabilization have been developed. Thermoshift
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FIGURE 5 | Microscopic assays for antibiotic effects on the nucleoid. Cells were treated with tyrocidine A, which has been described to bind to DNA (Ristow et al.,
1975). DAPI is used as a DNA dye and shows clear chromosome compaction after treatment. DnaN and ParB are DNA-binding proteins and reporters for impaired
replication. RecA is a reporter for DNA damage. RpoC is a reporter for impaired RNA synthesis. All these proteins showed a clear change in their localization pattern
after exposure to tyrocidine A. RpsB is a ribosomal protein that is used as reporter for impaired protein synthesis, which was included as a negative control and
showed no effect.
assays assess the resistance of proteins against denaturation by
heat and can be easily done in a gradient PCRmachine (Martinez
Molina et al., 2013; Mateus et al., 2017; Webb et al., 2019).
Drug affinity responsive target stability (DARTS) is a variant
based on stability toward a specific protease (Lomenick et al.,
2009). Stability of proteins from rates of oxidation (SPROX)
measures the stability of proteins to the denaturing oxidative
agent guanidinium hydrochloride (West et al., 2010; Strickland
et al., 2013).
Another method to identify a potential protein target is target
identification by chromatographic co-elution (TICC) (Chan
et al., 2012). This method uses non-denaturing HPLC separation
of cell lysate coupled with mass spectrometry. If a ligand
antibiotic binds to a protein, its chromatographic retention time
will change, and the protein will elute in a different fraction.
Proteins can be identified by mass spectrometry and those
appearing in different fractions in the treated and untreated
samples are candidate target proteins (Chan et al., 2012). The
current limitation with this method is that it has only been
employed for soluble cytosolic proteins so far.
Nucleic Acids
Nucleic acids and proteins that bind to them can be targeted
by antibiotics and AMPs alike. Dyes to label DNA in living
cells are well-established, most prominently DAPI and Hoechst
DNA stains, but many more are available covering a range of
fluorescent colors. These dyes allow observation of nucleoid
morphology and can reveal defects like chromosome compaction
or fragmentation (Wenzel et al., 2018a, 2019). Fluorescently
labeled proteins such as the recombinase RecA and DNA
polymerase can be used as reporters for DNA damage and
inhibition of replication, respectively (Figure 5, Table 4).
The anucleate cell blue assay is a simple E. coli reporter assay
that can be used to screen for compounds that target DNA
partitioning. It is based on a plasmid-encoded beta-galactosidase
that is regulated by a chromosome-encoded repressor. If DNA
segregation is inhibited, anucleate cells are produced, which are
stained blue due to derepression of the plasmid-encoded beta-
galactosidase gene (Wachi et al., 1999). This assay can be used to
identify topoisomerase inhibitors (Oyamada et al., 2006, 2007).
For transcription inhibition, RNA polymerase localization can
be observed. However, since it is a DNA-binding protein, it
will also be affected by DNA packing defects like chromosome
compaction (Wenzel et al., 2018a). In contrast to DNA, there
are not many RNA dyes available. Since research has mainly
focused on visualizing specific transcripts, sequence-specific
RNA labeling with RNA-binding proteins and hybridization
techniques is well-established (van Gijtenbeek and Kok, 2017; Fei
and Sharma, 2018). One general RNA dye is the green-fluorescent
SYTO variant RNASelect, which is five times more selective for
RNA over DNA and has been successfully employed for staining
of RNA in live E. coli (Bakshi et al., 2014).
OXIDATIVE STRESS
Disturbance of the respiratory chain can lead to the generation of
reactive oxygen species, which damage cellular macromolecules
including DNA, RNA, and membranes (Lee et al., 1998; Cabiscol
et al., 2000; Yoon et al., 2002). Some antibiotics also generate
reactive oxygen species by other means [e.g., nitrofurantoin (Tu
and McCalla, 1975)].
One way to examine whether a compound causes oxidative
damage is to monitor the oxidative stress response of bacteria.
The reaction of bacteria like B. subtilis and E. coli to oxidative cell
damage is well-characterized (Antelmann et al., 1997; Leichert
et al., 2003; Leichert and Jakob, 2004). Transcriptomic and
proteomic studies allowed delineating specific stress response
proteins that can now be used as oxidative stress markers. Their
induction can be monitored by reporter gene fusions or by
stress response profiling. Proteins that are well-suited for this
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are for example catalase, superoxide dismutase, and thioredoxin
(Leichert et al., 2003).
Several fluorescence dyes are available to detect reactive
oxygen species, for example CellRox, which fluoresces red in
presence of superoxide and singlet oxygen, the free radical sensor
Oxyburst green, and 2′, 7′-dichlorodihydrofluorescein diacetate
(DCFH-DA), which detects hydrogen peroxide and nitric oxide
(Wenzel et al., 2013; Arakha et al., 2015; Surewaard and Kubes,
2017). All of these dyes penetrate bacterial cells and are oxidized
to a fluorescent product by the respective reactive oxygen species.
A broad palette of other dyes with different reactive oxygen
species selectivity is commercially available, yet not all of them
have been used in bacteria.
Both of these methods are not a direct proof of oxidative cell
damage. Mass spectrometry however allows direct detection of
oxidative damage to proteins bymeasuring cysteines in their thiol
(reduced) and disulfide (oxidized) forms (Kozarova et al., 2007;
Sethuraman et al., 2007). To this end, isotope-coded affinity tags
(ICAT) can be used. Employing a selective labeling technique,
OxICAT, reduced and oxidized cysteines can be labeled with a
light or heavy isotope tag, respectively (Leichert et al., 2008). This
method has been further refined to also detect nitrosative stress
(NOxICAT) (Lindemann and Leichert, 2012).
CONCLUSION
The pressure of antimicrobial resistance has prompted an
urgent need for new antimicrobial compounds with novel
mechanisms of action. Understanding these mechanisms is
of high importance for two reasons. One the one hand, the
mechanism must simply be known prior to clinical approval. On
the other hand, it is of utmost importance to understand how
successful antibiotics work in order to develop better compounds
in the future. Antibiotics with single protein targets are inferior
to compounds with complex or multiple targets in terms
of resistance development (Brötz-Oesterhelt and Brunner, 2008)
and antibiotic discovery is slowly shifting toward multifunctional
compounds (Gajdács, 2019; Gray andWenzel, 2020b). This poses
a challenge for mode of action analysis, since these mechanisms
are less well-understood and more difficult to diagnose.
Moreover, it has become clear that antibiotic mechanisms may
differ in vitro and in in vivo and that compounds may have
additional targets in living cells (Müller et al., 2016b; Wenzel
et al., 2019; Grein et al., 2020). This underlines the importance
of in vivo mechanism of action studies. In this review, we have
summarized a number of useful techniques for in vivo mode of
action studies of antimicrobial compounds. We hope that it can
serve as guide to researchers, who are less familiar with this type
of experiments, to inspire new exciting mechanistic studies on
living bacteria.
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